Hemoglobin A1C testing frequency reimbursement
This UnitedHealthcare Community Plan reimbursement policy governs reimbursement and frequency limits for hemoglobin A1C (diabetes mellitus) testing billed on CMS-1500 or UB-04 forms for Medicaid products and affects all network and non-network providers submitting claims.
State Exceptions: Washington DC added; Colorado and Rhode Island removed.
Policy published.
Coverage Criteria for Hemoglobin A1C Testing
Coverage criteria for Hemoglobin A1C testing
Reimbursement is considered for the following procedure codes and conditions with a frequency limitation.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.